Screener
Intellia Therapeutics NTLA Proceeds From At The Market Offerings Unpaid At Period End
Proceeds From At The Market Offerings Unpaid At Period End at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept ntla:ProceedsFromAtTheMarketOfferingsUnpaidAtPeriodEnd.
The source filing: Intellia Therapeutics’s 10-K, filed February 26, 2026. Open the filing →
- Filed
- Feb 26, 2026, 4:06 PM EST
- Fiscal year
- FY2025
- Accession
- 0001193125-26-076550
FAQ
- What is Intellia Therapeutics's proceeds from at the market offerings unpaid at period end?
- Intellia Therapeutics (NTLA) reported proceeds from at the market offerings unpaid at period end of $0 in Q4 2025.
- What does proceeds from at the market offerings unpaid at period end mean?
- This metric tracks the value of equity sold through at-the-market (ATM) programs for which cash has not yet been received by the end of the reporting period. It provides visibility into pending capital inflows from equity financing activities. This is a key indicator of near-term liquidity and potential dilution that has been initiated but not yet settled.
Ask your AI about Intellia Therapeutics's proceeds from at the market offerings unpaid at period end.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude